MedPath

Disal

Disal® (furosemide injection) 50 mg/mL

Approved
Approval ID

88f58baf-4ec5-4d6f-a447-68af4b239318

Product Type

PRESCRIPTION ANIMAL DRUG LABEL

Effective Date

Apr 28, 2025

Manufacturers
FDA

Boehringer Ingelheim Animal Health USA Inc.

DUNS: 007134091

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Furosemide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0010-6737
Application NumberNADA131538
Product Classification
M
Marketing Category
C73593
G
Generic Name
Furosemide
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateApril 28, 2025
FDA Product Classification

INGREDIENTS (7)

FUROSEMIDEActive
Quantity: 50 mg in 1 mL
Code: 7LXU5N7ZO5
Classification: ACTIB
MIRIPIRIUM CHLORIDEInactive
Quantity: 0.2 mg in 1 mL
Code: 3D6CWI0P23
Classification: IACT
EDETATE DISODIUMInactive
Quantity: 1 mg in 1 mL
Code: 7FLD91C86K
Classification: IACT
SODIUM SULFITEInactive
Quantity: 1 mg in 1 mL
Code: VTK01UQK3G
Classification: IACT
SODIUM CHLORIDEInactive
Quantity: 2 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
2-AMINOETHANOLInactive
Quantity: 10 mg in 1 mL
Code: 5KV86114PT
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Disal - FDA Drug Approval Details